Changes in eGFR from baseline were significantly higher at 6, 12, and 18 months (1.34, 1.85, and 1.23 mL/min/1.73 m 2 , respectively) in the combination SGLT2i with semaglutide OW T2D group compared with the SGLT2i group (Fig
The interaction between retatrutide and other compounds is not well characterized outside of clinical trial settings
71 Glutamate is the main neurotransmitter in the central nervous system, and extracellular glutamate levels are maintained by the exchange of extracellular cysteine for intracellular glutamate
& Coulson, N
Common side effects: Headache Upper respiratory infection symptoms (sore throat, runny/stuffy nose) Constipation Vomiting Mouth ulcers Rare but serious side effects (seek medical attention): Heart failure (shortness of breath, swelling, sudden weight gain) Pancreatitis (persistent nausea/vomiting, severe abdominal/back pain) Allergic reactions (hives, facial swelling, difficulty breathing) Hypoglycemia when combined with insulin or sulfonylureas (hunger, sweating, confusion) Kidney problems (decreased function, failure requiring dialysis) Severe skin reactions (blisters, skin erosion) Severe joint pain What should you tell your healthcare provider before taking Januvia
